PTPRC and head and neck squamous cell carcinoma: To capture a representative number of immune and non-immune cells per patient, we sorted CD45+ (immune) and CD45– (epithelial and stromal) cells from freshly resected HNSCC tumors prior to scRNAseq (Fig. 1A).